Century Therapeutics Showcases CNTY-813 at EASD
PHILADELPHIA, July 9, 2026 Century Therapeutics announced that its CNTY-813 preclinical research has been selected for oral presentations at...
IPSC
Advertisement
RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
Fate Therapeutics to Present FT819 Data at ISSCR 2026
SAN DIEGO, July 6, 2026 Fate Therapeutics announced that preliminary clinical data from its investigational FT819 off-the-shelf CD19-targeting CAR...
Kenai Therapeutics Completes Phase 1b/2a REPLACE Trial Enrollment
SAN DIEGO, July 7, 2026 Kenai Therapeutics has announced the successful completion of patient enrollment in the Phase 1b/2a...
United Therapeutics Expands Cell Therapy with Thymmune Deal
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, July 2, 2026 United Therapeutics Corporation has announced the acquisition...
Advertisements
Aspen Neuroscience Completes Cohort 4 in ASPIRO Parkinson’s Trial
SAN DIEGO, June 30, 2026 Aspen Neuroscience, Inc. has announced the successful completion of Cohort 3 and Cohort 4...
Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment
CHICAGO, June 10, 2026 Syntax Bio announced a research and development collaboration with Mayo Clinic to accelerate the development...
TreeFrog’s TFG-001 Shows Strong Parkinson’s Recovery Data
BORDEAUX, France, May 25, 2026 TreeFrog Therapeutics announced new preclinical data showing that its investigational 3D neural microtissue cell...
Pluristyx and Qkine Sign Strategic iPSC Distribution Deal
SEATTLE, Washington & CAMBRIDGE, UK, May 1, 2026 Pluristyx and Qkine announced a reciprocal distribution agreement aimed at streamlining...
Century Therapeutics Highlights CNTY-813 Data at ADA
PHILADELPHIA, Pennsylvania, April 2026 Century Therapeutics announced that its investigational program CNTY-813 has been selected for oral presentation at...
Advertisement
